APONTIS PHARM. AG INH ON financial statements, including revenue, expenses, profit, and loss
The total revenue of APPH for the last semiannual is 22.73 M EUR, and it's 26.92% higher compared to the previous semiannual. The net income of H1 24 is 702.80 k EUR.